Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kevin J Harrington"'
Autor:
Lucinda Gunn, S.A. Bhide, Kate Newbold, Christopher M. Nutting, KH Wong, James Gilbert, Heba Soliman, Kevin J. Harrington, Pablo Nenclares
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 157
Background An intact sense of taste provides pleasure, supports sustenance and alerts the body to toxins. Head and neck cancer (HNC) patients who receive radiotherapy (RT) are high-risk for developing radiation-induced taste dysfunction. Advances in
Autor:
Roxy Senior, James Hooper, Kevin J. Harrington, Meng-Xing Tang, Dorothy M. Gujral, Christopher M. Nutting, Wing Keung Cheung, Benoy N. Shah, Sanjeev Bhattacharyya, Navtej S. Chahal
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 120(1)
Purpose Abnormal proliferation of adventitial vasa vasorum (vv) occurs early at sites of atherosclerosis and is thought to be an early biomarker of vascular damage. Contrast-enhanced ultrasound (CEUS) can detect this process. Its usefulness in irradi
Autor:
Sarah L. Gulliford, Shreerang Bhide, Aisha Miah, Ceri Powell, James P Morden, Christopher M. Nutting, Kate Newbold, Kevin J. Harrington, Ulrike Schick
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 110(3)
Fatigue during head and neck radiotherapy may be related to radiation dose to the central nervous system (CNS). The impact of patient, tumour, and dosimetric variables on acute fatigue was assessed in nasopharyngeal cancer patients undergoing chemora
Autor:
Sarah L. Gulliford, Kate Newbold, Christopher M. Nutting, Aisha Miah, Kevin J. Harrington, Shane Zaidi, Shreerang Bhide, Catharine H. Clark
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 106(3)
Purpose To describe the dose–response relationships for the different measures of salivary gland recovery following radical radiotherapy for locally advanced head and neck squamous cell cancers (LA-HNSCC). Methods and materials Dosimetric analysis
Autor:
Sarah L. Gulliford, Kate Newbold, Shreerang Bhide, Christopher M. Nutting, Kevin J. Harrington, Shane Zaidi, Aisha Miah
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 106(3)
Purpose: To determine whether concomitant chemotherapy increases the incidence of high grade xerostomia following parotid-sparing intensity-modulated radiotherapy (IMRT) in patients with locally advanced head and neck squamous cell cancer. Materials
Autor:
Marco Borri, Christopher M. Nutting, Dow-Mu Koh, Angela Riddell, Katie L. Newbold, Maria A. Schmidt, Kevin J. Harrington, Ceri Powell, Gary Cook, Mike Partridge, Shreerang Bhide
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 106(1)
BACKGROUND: When induction chemotherapy (IC) is used prior to chemoradiotherapy (CRT) in head and neck cancer (HNC), functional imaging (FI) may inform adaptation of treatment plans with the aim of optimising outcomes. Understanding the impact of IC
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 99(3)
Oncolytic viruses are investigational cancer treatments. They are currently being assessed as single agents or in combination with standard therapies such as external beam radiotherapy - a DNA damaging agent that is a standard of care for many tumour
Autor:
Reha N. Kazi, Kevin J. Harrington, Kate Newbold, Sara H. Gulliford, Iman El-Hariry, Shreeran Ga. Bhide, Christopher M. Nutting
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 93(3)
Aim of this study was to correlate dose to pharyngeal constrictors (PC) with subjective and observer-based assessments of swallowing in patients with head and neck cancer undergoing concomitant chemo-IMRT.Dose-volume histograms (DVHs) for superior co
Autor:
Elizabeth Miles, Roger A'Hern, Catharine H. Clark, Christopher M. Nutting, Kevin J. Harrington, M. Teresa Guerrero Urbano, David P. Dearnaley, M. Bidmead
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 77(3)
Background and purpose Intensity modulated radiotherapy (IMRT) at the Royal Marsden Hospital London was introduced in July 2001. Treatment delivery was dynamic using a single-phase technique. Concerns were raised regarding increased clinical workload